Glucagon vs Adiponectin

Head-to-head comparison of Glucagon (Glucagon) and Adiponectin (Adiponectin (Acrp30, AdipoQ)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyGlucagonAdiponectin
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameGlucagonAdiponectin (Acrp30, AdipoQ)
Molecular Weight3482.75~26.4 kDa (monomer)
Half-Life5-10 min~2-4 h
Amino Acids29244
Typical Dose1 mg IM/SC for severe hypoglycemia or 3 mg intranasalNo approved human dose; research use only
RouteIM|SC|IN|IVIV|SC
Purity≥98%≥98%
Studies Count9386
Research StatusApprovedPre-clinical

Glucagon Benefits

  • rapid hypoglycemia reversal
  • raises plasma glucose
  • useful in emergency rescue

Adiponectin Benefits

  • insulin sensitivity
  • fatty-acid oxidation
  • AMPK activation

Glucagon Dosing

1 mg IM/SC|3 mg intranasal

Adiponectin Dosing

not established|not established

Glucagon Side Effects

  • nausea
  • vomiting

Adiponectin Side Effects

  • unknown
  • immunogenicity risk

Research Overview

Glucagon

Clinical and emergency medicine use is well established for severe hypoglycemia, with newer stable formulations improving ease of administration.

Adiponectin

Preclinical and translational studies link adiponectin signaling with better glycemic control, lower inflammation, and improved lipid handling. Recombinant adiponectin and receptor-targeting approaches remain research tools rather than approved diabetes therapies.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Glucagon stacks with:

glucagonGlucaGenBaqsimiGvoke

Adiponectin stacks with:

Acrp30AdipoQ
diabetesmetabolicrescueglucose-regulationAMPKadipokineinsulin-sensitizingmetabolic-syndrome